Aqilion will join the BIO Digital 2021 meeting and partnering event and present the Company’s pipeline and the latest development in the pre-clinical Alnitak project. The goal of the Alnitak program is to develop drug candidates that bind to a target protein that is essential for both malignant disease development and for inflammatory conditions.

Share this page


Read more about our Protection of your personal data.